(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.
(Alliance News) - BP PLC on Monday announced it is teaming up with Tokyo-based JERA Co Inc to combine their offshore wind businesses to form a new joint venture.
Fidelity China noted the benchmark's rise was "mostly generated in September alone" following stimulus measures which included a rate cut by the People's Bank of China. According to the investor, ...
(Alliance News) - Inspecs Group PLC shares slumped on Monday as it warned its annual earnings will be down after recent weak trading.
"ISS states that Frasers has offered a superficial view of performance and no specific plans for change and the two Frasers candidates, Mike Ashley and Mike Lennon, have real conflicts of interest, ...
Jefferies raises London Stock Exchange price target to 13,500 (12,500) pence - 'buy' Comments and questions to
[email protected] Copyright 2024 Alliance News Ltd. All Rights Reserved.
On the Beach Group PLC, up 3.6% at 242.98 pence, 12-month range 127.75p-244.00p. The beach holidays retailer climbs again, looking set to extend its winning streak to nine days. On Tuesday last week, ...
(Alliance News) - IP Group PLC on Monday said it has agreed the sale of minority holdings in nine portfolio to a new fund managed by Lexham Capital Partners Ltd for around GBP15 million.
(Alliance News) - The UK Government will make a swift decision on whether to lift the ban on Islamist group Hayat Tahrir al-Sham, alias HTS, after it swept to power in Syria, ousting Bashar Assad's ...
(Alliance News) - Domino's Pizza Group PLC on Monday said it had reached an agreement for a new five-year framework with its franchise partners as it said it will face a GBP3.0 million a year hit from ...
"The breakthrough therapy designation granted by the FDA underscores the significant unmet need for new treatments for patients with previously treated EGFR-mutated non-small cell lung cancer who have ...
In addition, GSK said its Blenrep drug has been approved for priority review in China to treat sufferers of myeloma, a bone marrow cancer. The regulatory submission is supported by phase III ...